Dow Up 1.32% Nasdaq Up 1.60%

Alimera Sciences, Inc. (ALIM)

-NasdaqGM
5.46 0.65(13.51%) Oct 23, 4:00PM EDT
Prev Close:4.81
Open:4.86
Bid:N/A
Ask:6.19 x 100
1y Target Est:10.00
Beta:2.19
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.84 - 5.47
52wk Range:1.76 - 8.44
Volume:1,133,683
Avg Vol (3m):294,446
Market Cap:220.72M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

┬╗ More Headlines for ALIM

Comparison

Symbol% ChgMkt Cap
ALIMUp 13.51%220.72M
AGN54.49B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.36
Quarterly EPS Est (Sep-14) :-0.70
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback